Retrospective study links GLP-1 drugs to lower breast cancer mortality and recurrence, but experts question data quality
A 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.




